SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • April 6th, 2017 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 6th, 2017 Company Industry JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of November 28, 2016, between Stemcells, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).